Related Experiment Video

Updated: Feb 14, 2026

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

429

Development of siRNA payloads to target KRAS-mutant cancer

Tina L Yuan1, Christof Fellmann2, Chih-Shia Lee3

  • 1Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158, USA.

Cancer Discovery
|August 8, 2014
PubMed
Abstract

Insights

RNA interference (RNAi) therapies show promise for KRAS-mutant cancers. Researchers developed a validated siRNA library for combination gene silencing, effectively inhibiting KRAS-mutant colorectal cancer in vivo.

Area of Science:

  • Molecular biology
  • Genetics
  • Cancer therapy

Background:

  • RNA interference (RNAi) is a key technology for identifying therapeutic targets, including difficult ones like KRAS.
  • Effective RNAi therapy requires potent small interfering RNA (siRNA) payloads and reliable in vivo delivery for target inhibition.

Purpose of the Study:

  • To develop a library of potent siRNAs against RAS pathway genes using a functional "Sensor" assay.
  • To validate the in vitro and in vivo efficacy of these siRNAs for treating KRAS-mutant colorectal cancer.
  • To explore combination gene silencing strategies for enhanced therapeutic effects.

Main Methods:

  • Established a library of potent siRNAs targeting RAS pathway genes via a "Sensor" assay.
  • Administered Sensor siRNAs in vitro and in vivo to assess target suppression and delivery.
  • Evaluated KRAS siRNA alone and RAF effector node (A/B/CRAF) targeting siRNA in xenograft models.
  • Investigated combination payloads including KRAS with PIK3CA/B siRNAs.

Main Results:

  • Demonstrated efficient target suppression at low doses, minimizing off-target effects.
  • Validated KRAS siRNA and RAF-targeted siRNA as promising strategies for KRAS-mutant colorectal cancer.
  • Showed improved therapeutic efficacy with combination siRNA payloads (e.g., KRAS + PIK3CA/B).

Conclusions:

  • Developed a validated siRNA library for combination gene silencing in RAS pathway genes.
  • Validated siRNA-mediated inhibition of KRAS, RAF, or PI3K combinations impairs KRAS-mutant colorectal cancer growth in vivo.
  • Sensor siRNA technology provides a versatile platform for target identification and RNAi therapeutic development.

More Related Videos

Preparation of Exosomes for siRNA Delivery to Cancer Cells09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

26.1K
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.9K

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.6K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Small interfering RNAs (siRNA)02:30

Small interfering RNAs (siRNA)

No description available
4.7K
Sustainable Development01:43

Sustainable Development

As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
15.2K
Language Development01:22

Language Development

Children master language quickly and with relative ease, supported by both biological predisposition and reinforcement. B. F. Skinner (1957) proposed that language is learned through reinforcement, while Noam Chomsky (1965) argued that language acquisition mechanisms are biologically determined.
The critical period for language acquisition suggests that the ability to acquire language is at its peak early in life. As people age, this proficiency decreases. Language development begins very...
939